SRZN compared with IPSC: revenue, margins and what each company keeps, and the suppliers and customers both name

SRZNSurrozen, Inc.

Mkt capRevenueRevenue

IPSCCentury Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SRZNSurrozen, Inc.

IPSCCentury Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SRZN 6

—Boehringer Ingelheimunlistedsupplier

—Continental Stock Transfer & Trustunlistedsupplier

—Stanford Universityunlistedsupplier

—TD Securities (USA)unlistedsupplier

2 more · SRZN chain ›

Shared 0

No shared counterparties.

Only IPSC 7

BMYBristol-Myers Squibbcustomer

—FUJIFILM Cellular Dynamicsunlistedsupplier

—Catalent Dusseldorf GmbHunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Fcdi

unlistedsupplier

3 more · IPSC chain ›

SRZNSurrozen, Inc.

30.17▲+4.04%

Mkt cap$671.2MRevenue$5MQ2 FY26Revenue$3MFY25

IPSCCentury Therapeutics, Inc.

1.67▲+10.60%

Regular sessionNov 6 '26

Mkt cap$273.4MRevenue$109MQ1 FY25Revenue$7MFY24

Compare

Regular sessionNov 6 '26

SRZNSurrozen, Inc.

IPSCCentury Therapeutics, Inc.

30.17▲+4.04%

Price

1.67▲+10.60%

$671.2M

Mkt cap

$273.4M

Q2 FY26$5M

Revenue

$109MQ1 FY25

FY25$3M

Revenue

$7MFY24

SRZN30.17▲+4.04%vsIPSC1.67▲+10.60%Regular sessionNov 6 '26